Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: ImmuCell(ICCC) the Revenue is 10.36 M (+28.39%);the EBIT is 1.969 M (+76.21%);the EPS is 0.21 (+31.25%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B28.39%
----
----
EBIT
0.00B76.21%
----
----
EPS
0.2131.25%
----
----
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 13, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf